Arcadia Biosciences Filing Shows Selling Shareholders To Offer ~725.4K Shares Of Stock

Pursuant to this prospectus, the selling stockholders identified herein are offering on a resale basis an aggregate of 725,356 shares of our common stock that are issuable upon the exercise of outstanding warrants to

Benzinga · 12/11/2019 12:40

Pursuant to this prospectus, the selling stockholders identified herein are offering on a resale basis an aggregate of 725,356 shares of our common stock that are issuable upon the exercise of outstanding warrants to purchase our common stock. These warrants were issued in connection with a private placement we completed on September10, 2019. We will not receive any of the proceeds from the sale by the selling stockholders of the common stock. Upon any exercise of the warrants by payment of cash, however, we will receive the exercise price of the warrants.